These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17204946)

  • 21. [Therapeutic strategies for chronic hepatitis B recommended by the American Association for the Study of Liver Diseases].
    Wang YC; Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):623-4. PubMed ID: 15504297
    [No Abstract]   [Full Text] [Related]  

  • 22. Current therapy of chronic hepatitis B.
    Pardo M; Bartolomé J; Carreño V
    Arch Med Res; 2007 Aug; 38(6):661-77. PubMed ID: 17613358
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B].
    Kim JM; Choe BH; Chu MA; Cho SM
    Korean J Hepatol; 2009 Jun; 15(2):168-78. PubMed ID: 19581769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus carriers; natural course, diagnostic approach and treatment.
    Ranjan P; Aggarwal R
    Trop Gastroenterol; 2005; 26(2):58-65. PubMed ID: 16225046
    [No Abstract]   [Full Text] [Related]  

  • 25. Changing landscape of antiviral resistance management in chronic hepatitis B.
    Nguyen T; Locarnini S; Desmond P
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy of antiviral treatment on intrahepatic HBV DNA and histology in HBeAg -positive chronic hepatitis B patients].
    Lu HY; Zhuang LW; Yu YY; Si CW; Zheng JJ; Chen XY; Han ZH; Chen Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):54-6. PubMed ID: 18414702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy.
    Bourne EJ; Dienstag JL; Lopez VA; Sander TJ; Longlet JM; Hall JG; Kwiatkowski RW; Wright T; Lai CL; Condreay LD
    J Viral Hepat; 2007 Jan; 14(1):55-63. PubMed ID: 17212645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment with natural interferon (alfaferone) in clinical practice--our experience].
    Dybowska D; Halota W
    Przegl Epidemiol; 2007; 61(1):17-22. PubMed ID: 17702434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug resistance after lamivudine therapy for chronic hepatitis B.
    Sarrecchia C; Volpi A; Sordillo P; Andreoni M
    Int J Infect Dis; 2009 May; 13(3):e133-4. PubMed ID: 18990599
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis B reactivation prophylaxis in immune-suppressed patients.
    Torresin A; Feasi M; Cassola G
    Haematologica; 2008 Nov; 93(11):e65. PubMed ID: 18978291
    [No Abstract]   [Full Text] [Related]  

  • 32. [Application of serum hepatitis B virus large surface protein determination in lamivudine anti-viral therapy for patients with hepatitis B].
    Li GY; Sheng JL; Huang HJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):133-5. PubMed ID: 18574538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
    Liaw YF
    Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.
    Tanaka E; Matsumoto A; Yoshizawa K; Maki N
    Intervirology; 2008; 51 Suppl 1():3-6. PubMed ID: 18544941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy.
    Kim JH; Yu SK; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Lee CH; Byun KS
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1220-5. PubMed ID: 17532786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PGS consensus statement on management of hepatitis B virus infection--2003.
    Abbas Z; Jafri W; Shah SH; Khokhar N; Zuberi SJ;
    J Pak Med Assoc; 2004 Mar; 54(3):150-8. PubMed ID: 15129877
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis B immunization after liver transplantation: what is the answer?
    Poland GA; Poterucha JJ
    Liver Transpl; 2005 Oct; 11(10):1181-3. PubMed ID: 16184563
    [No Abstract]   [Full Text] [Related]  

  • 39. [Detection of hepatitis B virus carrier state in unpaid donors on the ships].
    Zavgorodniĭ GN
    Voen Med Zh; 1982 Nov; (11):44. PubMed ID: 7179784
    [No Abstract]   [Full Text] [Related]  

  • 40. [Autoantibodies in chronic hepatitis and chronic glomerulonephritis in children infected with hepatitis B virus].
    Michalak T; Nazarewicz T; Nowoslawski A
    Pediatr Pol; 1976 Jan; 51(1):1-7. PubMed ID: 1246473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.